Key Insights

Highlights

Success Rate

86% trial completion

Published Results

28 trials with published results (5%)

Research Maturity

189 completed trials (32% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

5.4%

32 terminated out of 588 trials

Success Rate

85.5%

-1.0% vs benchmark

Late-Stage Pipeline

18%

107 trials in Phase 3/4

Results Transparency

15%

28 of 189 completed with results

Key Signals

28 with results86% success32 terminated

Data Visualizations

Phase Distribution

450Total
Not Applicable (199)
Early P 1 (3)
P 1 (49)
P 2 (92)
P 3 (74)
P 4 (33)

Trial Status

Completed189
Recruiting141
Not Yet Recruiting98
Unknown95
Terminated32
Active Not Recruiting15

Trial Success Rate

85.5%

Benchmark: 86.5%

Based on 189 completed trials

Clinical Trials (588)

Showing 20 of 20 trials
NCT05691244Phase 3RecruitingPrimary

Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

NCT07263776Phase 3Active Not RecruitingPrimary

Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2

NCT05326932Not ApplicableRecruitingPrimary

Large Artery Occlusion Treated in Extended Time With Mechanical Thrombectomy Trial

NCT06823128Not ApplicableTerminatedPrimary

Safety and Efficacy of Remote Ischemic Conditioning in Patients With Severe Stenosis or Occlusion of Anterior Intracranial Circulation Vessels

NCT07638462Not ApplicableNot Yet RecruitingPrimary

RIsE Stroke Mobility Study

NCT06696820Phase 2CompletedPrimary

Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke

NCT07361302Phase 3RecruitingPrimary

A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

NCT07635758Phase 1RecruitingPrimary

Human Placenta-derived 3D Mesenchymal Stem Cells(Guojianqingke)

NCT07626541Phase 2RecruitingPrimary

Fructose for Acute Ischemic Stroke

NCT07094763Not ApplicableRecruitingPrimary

Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset

NCT07628933Phase 1Not Yet RecruitingPrimary

A Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells for Acute Ischemic Stroke

NCT07598799Not ApplicableNot Yet RecruitingPrimary

Rapid Local Ischemic Postconditioning on Stroke After Thrombectomy

NCT07316049Not ApplicableNot Yet RecruitingPrimary

Construction and Evaluation of an Intelligent Decision System for Reperfusion Therapy in Acute Ischemic Stroke

NCT07624396Not Yet RecruitingPrimary

Association Between Circulating BDNF Levels and Cardioembolic Strokes in Patients Treated for Ischemic Stroke

NCT07555977Not ApplicableNot Yet RecruitingPrimary

SUPERSTAR: Aspiration vs. Stent Retriever in Anterior Circulation LVO

NCT06781385Phase 2Enrolling By InvitationPrimary

Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke

NCT07621796Phase 3Not Yet RecruitingPrimary

Efficacy and Safety of Tenecteplase Among acutE Ischemic Stroke Patients With Recent Ingestion of Direct Oral Anticoagulant

NCT07618052Not ApplicableNot Yet Recruiting

Efficacy and Safety of Bailout Intracranial Angioplasty or Stenting After Thrombectomy for Acute Intracranial Atherosclerotic Large Vessel Occlusion (ANGEL-REBOOT 2)

NCT07617870Phase 3Not Yet RecruitingPrimary

Pro-urokinase for Extended-Window Posterior Circulation Stroke

NCT07163299Phase 1Enrolling By InvitationPrimary

Intra-arterial Selective Hypothermic Magnesium Sulfate Infusion in Combination With Endovascular Thrombectomy in Acute Ischemic Stroke

Scroll to load more

Research Network

Activity Timeline